北京
分享至
亨迪药业公告，公司精氨酸布洛芬颗粒近日获得国家药监局核准签发的《药品注册证书》，规格为0.2g；0.4g，批准按（甲类）非处方药管理。
本文源自：金融界AI电报
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
